A case of severe actinic prurigo successfully treated with thalidomide
✍ Scribed by Jonathan CH Ng; Peter A Foley; Rohan B Crouch; Christopher S Baker
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 169 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0004-8380
No coin nor oath required. For personal study only.
✦ Synopsis
SUMMARY
Actinic prurigo is an uncommon and usually persistent idiopathic photodermatosis with typical human leukocyte antigen (HLA) associations (HLA‐DR4, particularly subtypes DRB1*0407 and DRB1*0401). Although its mechanism of action is not clearly understood, thalidomide has been shown to be particularly efficacious in treating actinic prurigo, among other conditions. A 31‐year‐old Australian woman who had suffered actinic prurigo for most of her life was treated with two courses of thalidomide (50–100 mg nocte) over consecutive summers. Remission was observed after cessation of the second course of thalidomide and had continued 4 years later. Abnormalities in the cutaneous response to ultraviolet radiation at the time of diagnosis, detected by monochromator phototesting, reverted to normal following treatment.
📜 SIMILAR VOLUMES
## Abstract Viral loads and cytokine responses Epstein–Barr virus (EBV) were measured in an 18‐year‐old boy with severe glandular fever complicated by a mild anaemia, severe thrombocytopaenia and neutropaenia. Hepatosplenomegaly was detected by abdominal ultrasound in the presence of significant he
ethamine, oncovin, procarbazine, and prednisone) and mantle radiation.